Spectrophotometric Estimation of Flutamide in Pure and in Pharmaceutical Preparations

Table 4

Results of recovery by standard-addition method.

Tablet brand name		Method A				Method B			Method C
	FA tablet; μg/mL	Pure FA added,; μg/mL	Total found; μg/mL	Pure FA recovered*; %  ± SD	Pure FA added,; μg/mL	Total found; μg/mL	Pure FA recovered*; %  ± SD	Pure FA added,; μg/mL	Total found; μg/mL	Pure FA recovered*; %  ± SD
	2	2	4.02	100.82 ± 0.20	2	4.01	100.78 ± 0.31	2	4.02	100.74 ± 0.27
CYTOMID^a 250 mg	2	4	5.98	99.40 ± 0.49	4	6.05	101.14 ± 0.50	4	6.04	101.08 ± 0.34
	2	6	8.04	100.70 ± 0.52	6	8.07	101.15 ± 0.38	6	7.97	99.54 ± 0.53
	2	2	3.98	99.22 ± 0.22	2	4.01	100.29 ± 0.30	2	4.04	101.88 ± 0.30
DROGENIL^b 250 mg	2	4	5.97	99.46 ± 0.33	4	6.07	101.79 ± 0.13	4	5.99	99.66 ± 0.43
	2	6	8.02	100.26 ± 0.39	6	8.03	100.52 ± 0.43	6	8.02	100.27 ± 0.47

*Mean value of three determinations.
^aMarketed by Cipla (Pvt) Ltd; ^bMarketed by Fulford.